Biotech

All Articles

Less than a year in, BenevolentAI chief executive officer is out-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of significant leadership hirings, firings and a...

Roche MAGE-A4 trial removed after important assessment

.Roche has produced another MAGE-A4 system fade away, withdrawing a period 1 trial of a T-cell bispe...

FDA puts predisposed hang on BioNTech-OncoC4 period 3 test

.The FDA has carried out a partial hold on a phase 3 non-small tissue lung cancer practice run by Bi...

REGiMMUNE, Kiji combine to generate Treg 'super firm,' strategy IPO

.Taiwan's REGiMMUNE as well as Europe-based Kiji Therapeutics are combining to generate an internati...

With test gain, Merck seeks to handle Sanofi, AZ in RSV

.Three months after uncovering that its own respiratory syncytial infection (RSV) preventive antitox...

Noema checks off phase 2a Tourette win for ex-Roche particle

.Noema Pharma has actually acquired a period 2a win for its own Tourette disorder medicine candidate...

Terray puts together $120M set B to breakthrough AI-powered particles

.Terray Therapeutics has raked in $120 million for a set B fundraise as the AI-focused biotech inten...

Kezar denies Concentra buyout that 'undervalues' the biotech

.Kezar Life Sciences has actually come to be the most recent biotech to make a decision that it can ...

Wave hails human RNA editing and enhancing to begin with for GSK-partnered prospect

.Surge Life Sciences has taken an action toward validating a brand new method, becoming the initial ...

Chinese insulin producer's GLP-1 tops Ozempic in ph. 2

.Mandarin blood insulin creator Gan &amp Lee Pharmaceuticals is falling to the weight problems plane...